ACE2 and COVID-19: It has been proposed that ACE2 receptor degradation during SARS-CoV-2 infection disrupts protection by ACE2 from inflammatory processes through the RAS and bradykinin pathways, possibly explaining patterns of COVID-19 severity with age and sex (Bastolla, 2020; Bastolla et al., 2021).